In conclusion, we could see that both the EndocineTM adjuvant and the N3OA adjuvant together with influenza antigen induced significantly higher titers of influenza-specific mucosal IgA, HAI- and NT-antibodies compared to the non-adjuvanted group. The gene discussed is CD79A; the disease is influenza.